Cargando…
The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease
Combination therapy with glucocorticoids, cyclophosphamide, and plasmapheresis is recommended as the standard treatment for anti-glomerular basement membrane (anti-GBM) disease, but the prognosis of this disease remains poor. Several immunobiological agents have been administered or are expected to...
Autores principales: | Yamashita, Marina, Takayasu, Mamiko, Maruyama, Hiroshi, Hirayama, Kouichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673378/ https://www.ncbi.nlm.nih.gov/pubmed/38004064 http://dx.doi.org/10.3390/medicina59112014 |
Ejemplares similares
-
Transformation of membranous nephropathy into antiglomerular-basement membrane glomerluonephritis
por: Szeki, Iren, et al.
Publicado: (2011) -
Atypical Noncrescentic Antiglomerular Basement Membrane Disease With Concurrent Thin Basement Membrane Nephropathy
por: Singhal, Pooja, et al.
Publicado: (2018) -
A curious case of antiglomerular basement membrane antibody disease
por: Koratala, Abhilash, et al.
Publicado: (2018) -
Antiglomerular Basement Membrane Disease Combined with IgA Nephropathy
por: Gupta, Yashita, et al.
Publicado: (2019) -
A Case of Alport Syndrome with Posttransplant Antiglomerular Basement Membrane Disease despite Negative Antiglomerular Basement Membrane Antibodies by EIA Treated with Plasmapheresis and Intravenous Immunoglobulin
por: Armstead, Sumiko I., et al.
Publicado: (2013)